Phase 1 Study of the Protein Deubiquitinase Inhibitor VLX1570 in Patients With Relapsed and/or Refractory Multiple Myeloma
Investigational New Drugs - Netherlands
doi 10.1007/s10637-020-00915-4
Full Text
Open PDFAbstract
Available in full text
Date
March 3, 2020
Authors
Publisher
Springer Science and Business Media LLC